0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Oxaprozin Active Pharmaceutical Ingredients Market Insights, Forecast to 2027
Published Date: September 2021
|
Report Code: QYRE-Auto-2L8034
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global and United States Oxaprozin Active Pharmaceutical Ingredients Market Insights Forecast to 2027

Global and United States Oxaprozin Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

Code: QYRE-Auto-2L8034
Report
September 2021
Pages:138
QYResearch
Description
Table of Content
Tables & Figures

Oxaprozin API Market

Oxaprozin, also known as oxaprozinum, is a nonsteroidal anti-inflammatory drug, used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.

This report focuses on global and United States Oxaprozin Active Pharmaceutical Ingredients market.

In 2020, the global Oxaprozin Active Pharmaceutical Ingredients market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Oxaprozin Active Pharmaceutical Ingredients market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Oxaprozin Active Pharmaceutical Ingredients market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oxaprozin Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Oxaprozin Active Pharmaceutical Ingredients market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

By Type

  • Purity (99%-99.5%)
  • Purity (above 99.5%)
  • Purity (below 99 %)

By Application

  • Reating Pain
  • Fever
  • Inflammation
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

By Company

  • Granules India Limited
  • Huagang Pharm
  • Hebei Jiheng Pharmaceutical
  • Zhejiang Kangle Pharmaceutical
  • Pfizer
  • Taj Pharmaceuticals Ltd
  • ScinoPharm
1 Study Coverage
1.1 Oxaprozin Active Pharmaceutical Ingredients Product Introduction
1.2 Market by Type
1.2.1 Global Oxaprozin Active Pharmaceutical Ingredients Market Size Growth Rate by Type
1.2.2 Purity (99%-99.5%)
1.2.3 Purity (above 99.5%)
1.2.4 Purity (below 99 %)
1.3 Market by Application
1.3.1 Global Oxaprozin Active Pharmaceutical Ingredients Market Size Growth Rate by Application
1.3.2 Reating Pain
1.3.3 Fever
1.3.4 Inflammation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oxaprozin Active Pharmaceutical Ingredients Market Size, Estimates and Forecasts
2.1.1 Global Oxaprozin Active Pharmaceutical Ingredients Revenue 2016-2027
2.1.2 Global Oxaprozin Active Pharmaceutical Ingredients Sales 2016-2027
2.2 Global Oxaprozin Active Pharmaceutical Ingredients, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oxaprozin Active Pharmaceutical Ingredients Historical Market Size by Region (2016-2021)
2.3.1 Global Oxaprozin Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oxaprozin Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oxaprozin Active Pharmaceutical Ingredients Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oxaprozin Active Pharmaceutical Ingredients Sales Forecast by Region (2022-2027)
2.4.2 Global Oxaprozin Active Pharmaceutical Ingredients Revenue Forecast by Region (2022-2027)
3 Global Oxaprozin Active Pharmaceutical Ingredients Competitor Landscape by Players
3.1 Global Top Oxaprozin Active Pharmaceutical Ingredients Manufacturers by Sales
3.1.1 Global Oxaprozin Active Pharmaceutical Ingredients Sales by Manufacturer (2016-2021)
3.1.2 Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oxaprozin Active Pharmaceutical Ingredients Manufacturers by Revenue
3.2.1 Key Oxaprozin Active Pharmaceutical Ingredients Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oxaprozin Active Pharmaceutical Ingredients Revenue by Manufacturers (2016-2021)
3.2.3 Global Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oxaprozin Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oxaprozin Active Pharmaceutical Ingredients Revenue in 2020
3.2.6 Global Oxaprozin Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oxaprozin Active Pharmaceutical Ingredients Price by Manufacturers
3.4 Global Oxaprozin Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
3.4.1 Oxaprozin Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oxaprozin Active Pharmaceutical Ingredients Product Type
3.4.3 Date of International Manufacturers Enter into Oxaprozin Active Pharmaceutical Ingredients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oxaprozin Active Pharmaceutical Ingredients Market Size by Type (2016-2021)
4.1.1 Global Oxaprozin Active Pharmaceutical Ingredients Sales by Type (2016-2021)
4.1.2 Global Oxaprozin Active Pharmaceutical Ingredients Revenue by Type (2016-2021)
4.1.3 Oxaprozin Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Type (2022-2027)
4.2.1 Global Oxaprozin Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027)
4.2.2 Global Oxaprozin Active Pharmaceutical Ingredients Revenue Forecast by Type (2022-2027)
4.2.3 Oxaprozin Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oxaprozin Active Pharmaceutical Ingredients Market Size by Application (2016-2021)
5.1.1 Global Oxaprozin Active Pharmaceutical Ingredients Sales by Application (2016-2021)
5.1.2 Global Oxaprozin Active Pharmaceutical Ingredients Revenue by Application (2016-2021)
5.1.3 Oxaprozin Active Pharmaceutical Ingredients Price by Application (2016-2021)
5.2 Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Application (2022-2027)
5.2.1 Global Oxaprozin Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027)
5.2.2 Global Oxaprozin Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027)
5.2.3 Global Oxaprozin Active Pharmaceutical Ingredients Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Oxaprozin Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
6.1.1 United States Oxaprozin Active Pharmaceutical Ingredients Sales YoY Growth 2016-2027
6.1.2 United States Oxaprozin Active Pharmaceutical Ingredients Revenue YoY Growth 2016-2027
6.1.3 United States Oxaprozin Active Pharmaceutical Ingredients Market Share in Global Market 2016-2027
6.2 United States Oxaprozin Active Pharmaceutical Ingredients Market Size by Players (International and Local Players)
6.2.1 United States Top Oxaprozin Active Pharmaceutical Ingredients Players by Sales (2016-2021)
6.2.2 United States Top Oxaprozin Active Pharmaceutical Ingredients Players by Revenue (2016-2021)
6.3 United States Oxaprozin Active Pharmaceutical Ingredients Historic Market Review by Type (2016-2021)
6.3.1 United States Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
6.3.2 United States Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
6.3.3 United States Oxaprozin Active Pharmaceutical Ingredients Price by Type (2016-2021)
6.4 United States Oxaprozin Active Pharmaceutical Ingredients Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Oxaprozin Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027)
6.4.2 United States Oxaprozin Active Pharmaceutical Ingredients Revenue Forecast by Type (2022-2027)
6.4.3 United States Oxaprozin Active Pharmaceutical Ingredients Price Forecast by Type (2022-2027)
6.5 United States Oxaprozin Active Pharmaceutical Ingredients Historic Market Review by Application (2016-2021)
6.5.1 United States Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
6.5.2 United States Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2021)
6.5.3 United States Oxaprozin Active Pharmaceutical Ingredients Price by Application (2016-2021)
6.6 United States Oxaprozin Active Pharmaceutical Ingredients Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Oxaprozin Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027)
6.6.2 United States Oxaprozin Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027)
6.6.3 United States Oxaprozin Active Pharmaceutical Ingredients Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oxaprozin Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
7.2 North America Oxaprozin Active Pharmaceutical Ingredients Market Facts & Figures by Country
7.2.1 North America Oxaprozin Active Pharmaceutical Ingredients Sales by Country (2016-2021)
7.2.2 North America Oxaprozin Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Market Facts & Figures by Region
8.2.1 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Sales by Region (2016-2021)
8.2.2 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Oxaprozin Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
9.2 Europe Oxaprozin Active Pharmaceutical Ingredients Market Facts & Figures by Country
9.2.1 Europe Oxaprozin Active Pharmaceutical Ingredients Sales by Country (2016-2021)
9.2.2 Europe Oxaprozin Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oxaprozin Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
10.2 Latin America Oxaprozin Active Pharmaceutical Ingredients Market Facts & Figures by Country
10.2.1 Latin America Oxaprozin Active Pharmaceutical Ingredients Sales by Country (2016-2021)
10.2.2 Latin America Oxaprozin Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Market Facts & Figures by Country
11.2.1 Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Granules India Limited
12.1.1 Granules India Limited Corporation Information
12.1.2 Granules India Limited Description and Business Overview
12.1.3 Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Products Offered
12.1.5 Granules India Limited Recent Development
12.2 Huagang Pharm
12.2.1 Huagang Pharm Corporation Information
12.2.2 Huagang Pharm Description and Business Overview
12.2.3 Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Products Offered
12.2.5 Huagang Pharm Recent Development
12.3 Hebei Jiheng Pharmaceutical
12.3.1 Hebei Jiheng Pharmaceutical Corporation Information
12.3.2 Hebei Jiheng Pharmaceutical Description and Business Overview
12.3.3 Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Products Offered
12.3.5 Hebei Jiheng Pharmaceutical Recent Development
12.4 Zhejiang Kangle Pharmaceutical
12.4.1 Zhejiang Kangle Pharmaceutical Corporation Information
12.4.2 Zhejiang Kangle Pharmaceutical Description and Business Overview
12.4.3 Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Products Offered
12.4.5 Zhejiang Kangle Pharmaceutical Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Oxaprozin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Oxaprozin Active Pharmaceutical Ingredients Products Offered
12.5.5 Pfizer Recent Development
12.6 Taj Pharmaceuticals Ltd
12.6.1 Taj Pharmaceuticals Ltd Corporation Information
12.6.2 Taj Pharmaceuticals Ltd Description and Business Overview
12.6.3 Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Products Offered
12.6.5 Taj Pharmaceuticals Ltd Recent Development
12.7 ScinoPharm
12.7.1 ScinoPharm Corporation Information
12.7.2 ScinoPharm Description and Business Overview
12.7.3 ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.7.4 ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Products Offered
12.7.5 ScinoPharm Recent Development
12.11 Granules India Limited
12.11.1 Granules India Limited Corporation Information
12.11.2 Granules India Limited Description and Business Overview
12.11.3 Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Products Offered
12.11.5 Granules India Limited Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oxaprozin Active Pharmaceutical Ingredients Industry Trends
13.2 Oxaprozin Active Pharmaceutical Ingredients Market Drivers
13.3 Oxaprozin Active Pharmaceutical Ingredients Market Challenges
13.4 Oxaprozin Active Pharmaceutical Ingredients Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oxaprozin Active Pharmaceutical Ingredients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Oxaprozin Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Purity (99%-99.5%)
    Table 3. Major Manufacturers of Purity (above 99.5%)
    Table 4. Major Manufacturers of Purity (below 99 %)
    Table 5. Global Oxaprozin Active Pharmaceutical Ingredients Market Size Growth Rate by Application (2021-2027) & (Kiloton)
    Table 6. Global Oxaprozin Active Pharmaceutical Ingredients Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027
    Table 7. Global Oxaprozin Active Pharmaceutical Ingredients Sales by Regions (2016-2021) & (Kiloton)
    Table 8. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Regions (2016-2021)
    Table 9. Global Oxaprozin Active Pharmaceutical Ingredients Revenue by Regions (2016-2021) & (US$ Million)
    Table 10. Global Oxaprozin Active Pharmaceutical Ingredients Sales Forecast by Region (2022-2027) & (Kiloton)
    Table 11. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2022-2027)
    Table 12. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 13. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2022-2027)
    Table 14. Global Oxaprozin Active Pharmaceutical Ingredients Sales by Manufacturers (2016-2021) (Kiloton)
    Table 15. Global Oxaprozin Active Pharmaceutical Ingredients Sales Share by Manufacturers (2016-2021)
    Table 16. Ranking of Global Top Oxaprozin Active Pharmaceutical Ingredients Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Oxaprozin Active Pharmaceutical Ingredients Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 18. Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2016-2021)
    Table 19. Global Oxaprozin Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 20. Global Oxaprozin Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaprozin Active Pharmaceutical Ingredients as of 2020)
    Table 21. Key Manufacturers Oxaprozin Active Pharmaceutical Ingredients Price (2016-2021) (US$/Ton)
    Table 22. Oxaprozin Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Oxaprozin Active Pharmaceutical Ingredients Product Type
    Table 24. Date of International Manufacturers Enter into Oxaprozin Active Pharmaceutical Ingredients Market
    Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oxaprozin Active Pharmaceutical Ingredients Sales by Type (2016-2021) (Kiloton)
    Table 27. Global Oxaprozin Active Pharmaceutical Ingredients Sales Share by Type (2016-2021)
    Table 28. Global Oxaprozin Active Pharmaceutical Ingredients Revenue by Type (2016-2021) (US$ Million)
    Table 29. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Type (2016-2021)
    Table 30. Oxaprozin Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton)
    Table 31. Global Oxaprozin Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027) & (Kiloton)
    Table 32. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2022-2027)
    Table 33. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Forecast V (2022-2027) & (US$ Million)
    Table 34. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share Forecast by Type (2022-2027)
    Table 35. Global Oxaprozin Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton)
    Table 36. Global Oxaprozin Active Pharmaceutical Ingredients Sales by Application (2016-2021) (Kiloton)
    Table 37. Global Oxaprozin Active Pharmaceutical Ingredients Sales Share by Application (2016-2021)
    Table 38. Global Oxaprozin Active Pharmaceutical Ingredients Revenue by Application (2016-2021) (US$ Million)
    Table 39. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Application (2016-2021)
    Table 40. Oxaprozin Active Pharmaceutical Ingredients Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton)
    Table 41. Global Oxaprozin Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027) & (Kiloton)
    Table 42. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2022-2027)
    Table 43. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 44. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share Forecast by Application (2022-2027)
    Table 45. Global Oxaprozin Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton)
    Table 46. United States Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton) of Key Companies (2016-2021)
    Table 47. United States Oxaprozin Active Pharmaceutical Ingredients Sales Share by Company (2016-2021)
    Table 48. United States Oxaprozin Active Pharmaceutical Ingredients Revenue (US$ Million) by Company (2016-2021)
    Table 49. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Company (2016-2021)
    Table 50. United States Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton) by Type (2016-2021)
    Table 51. United States Oxaprozin Active Pharmaceutical Ingredients Sales Share by Type (2016-2021)
    Table 52. United States Oxaprozin Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 53. United States Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Type (2016-2021)
    Table 54. United States Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton) by Type (2022-2027)
    Table 55. United States Oxaprozin Active Pharmaceutical Ingredients Sales Share by Type (2022-2027)
    Table 56. United States Oxaprozin Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 57. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Type (2022-2027)
    Table 58. United States Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Type (2022-2027)
    Table 59. United States Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton) by Application (2016-2021)
    Table 60. United States Oxaprozin Active Pharmaceutical Ingredients Sales Share by Application (2016-2021)
    Table 61. United States Oxaprozin Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 62. United States Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Application (2016-2021)
    Table 63. United States Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton) by Application (2022-2027)
    Table 64. United States Oxaprozin Active Pharmaceutical Ingredients Sales Share by Application (2022-2027)
    Table 65. United States Oxaprozin Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 66. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Application (2022-2027)
    Table 67. United States Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Application (2022-2027)
    Table 68. North America Oxaprozin Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
    Table 69. North America Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
    Table 70. North America Oxaprozin Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
    Table 71. North America Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
    Table 72. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Sales by Region (2016-2021) & (Kiloton)
    Table 73. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
    Table 74. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & (US$ Million)
    Table 75. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
    Table 76. Europe Oxaprozin Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
    Table 77. Europe Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
    Table 78. Europe Oxaprozin Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
    Table 79. Europe Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
    Table 80. Latin America Oxaprozin Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
    Table 81. Latin America Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
    Table 82. Latin Americaa Oxaprozin Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
    Table 83. Latin America Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
    Table 84. Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
    Table 85. Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
    Table 86. Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
    Table 87. Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
    Table 88. Granules India Limited Corporation Information
    Table 89. Granules India Limited Description and Business Overview
    Table 90. Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 91. Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Product
    Table 92. Granules India Limited Recent Development
    Table 93. Huagang Pharm Corporation Information
    Table 94. Huagang Pharm Description and Business Overview
    Table 95. Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 96. Huagang Pharm Product
    Table 97. Huagang Pharm Recent Development
    Table 98. Hebei Jiheng Pharmaceutical Corporation Information
    Table 99. Hebei Jiheng Pharmaceutical Description and Business Overview
    Table 100. Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 101. Hebei Jiheng Pharmaceutical Product
    Table 102. Hebei Jiheng Pharmaceutical Recent Development
    Table 103. Zhejiang Kangle Pharmaceutical Corporation Information
    Table 104. Zhejiang Kangle Pharmaceutical Description and Business Overview
    Table 105. Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 106. Zhejiang Kangle Pharmaceutical Product
    Table 107. Zhejiang Kangle Pharmaceutical Recent Development
    Table 108. Pfizer Corporation Information
    Table 109. Pfizer Description and Business Overview
    Table 110. Pfizer Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 111. Pfizer Product
    Table 112. Pfizer Recent Development
    Table 113. Taj Pharmaceuticals Ltd Corporation Information
    Table 114. Taj Pharmaceuticals Ltd Description and Business Overview
    Table 115. Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 116. Taj Pharmaceuticals Ltd Product
    Table 117. Taj Pharmaceuticals Ltd Recent Development
    Table 118. ScinoPharm Corporation Information
    Table 119. ScinoPharm Description and Business Overview
    Table 120. ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 121. ScinoPharm Product
    Table 122. ScinoPharm Recent Development
    Table 123. Oxaprozin Active Pharmaceutical Ingredients Market Trends
    Table 124. Oxaprozin Active Pharmaceutical Ingredients Market Drivers
    Table 125. Oxaprozin Active Pharmaceutical Ingredients Market Challenges
    Table 126. Oxaprozin Active Pharmaceutical Ingredients Market Restraints
    Table 127. Oxaprozin Active Pharmaceutical Ingredients Customers List
    Table 128. Oxaprozin Active Pharmaceutical Ingredients Distributors List
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oxaprozin Active Pharmaceutical Ingredients Product Picture
    Figure 2. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Type in 2020 & 2027
    Figure 3. Purity (99%-99.5%) Product Picture
    Figure 4. Purity (above 99.5%) Product Picture
    Figure 5. Purity (below 99 %) Product Picture
    Figure 6. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Application in 2020 & 2027
    Figure 7. Reating Pain
    Figure 8. Fever
    Figure 9. Inflammation
    Figure 10. Others
    Figure 11. Oxaprozin Active Pharmaceutical Ingredients Report Years Considered
    Figure 12. Global Oxaprozin Active Pharmaceutical Ingredients Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Oxaprozin Active Pharmaceutical Ingredients Market Size 2016-2027 (US$ Million)
    Figure 14. Global Oxaprozin Active Pharmaceutical Ingredients Sales 2016-2027 (Kiloton)
    Figure 15. Global Oxaprozin Active Pharmaceutical Ingredients Market Size Market Share by Region: 2021 Versus 2027
    Figure 16. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
    Figure 17. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
    Figure 18. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
    Figure 19. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
    Figure 20. Global Oxaprozin Active Pharmaceutical Ingredients Sales Share by Manufacturer in 2020
    Figure 21. The Top 10 and 5 Players Market Share by Oxaprozin Active Pharmaceutical Ingredients Revenue in 2020
    Figure 22. Oxaprozin Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 23. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
    Figure 24. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
    Figure 25. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
    Figure 26. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Type in 2020
    Figure 27. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
    Figure 28. Global Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
    Figure 29. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2021)
    Figure 30. Global Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Application in 2020
    Figure 31. United States Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate 2016-2027 (Kiloton)
    Figure 32. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 33. United States Oxaprozin Active Pharmaceutical Ingredients Market Share in Global Market 2016-2027
    Figure 34. United States 5 and 10 Largest Oxaprozin Active Pharmaceutical Ingredients Players Market Share by Revenue in Oxaprozin Active Pharmaceutical Ingredients in 2020
    Figure 35. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Type (2016-2021)
    Figure 36. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate by Type in 2016 & 2020
    Figure 37. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Share by Application (2016-2021)
    Figure 38. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate by Application in 2016 & 2020
    Figure 39. North America Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 40. North America Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 41. North America Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
    Figure 42. North America Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
    Figure 43. United States Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 44. United States Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Canada Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 46. Canada Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 47. Europe Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 48. Europe Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 49. Europe Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
    Figure 50. Europe Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
    Figure 51. Germany Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 52. Germany Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. France Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 54. France Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. U.K. Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 56. U.K. Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Italy Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 58. Italy Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Russia Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 60. Russia Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 61. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 62. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 63. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
    Figure 64. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
    Figure 65. China Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 66. China Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. Japan Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 68. Japan Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. South Korea Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 70. South Korea Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. India Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 72. India Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Australia Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 74. Australia Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. China Taiwan Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 76. China Taiwan Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Indonesia Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 78. Indonesia Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Thailand Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 80. Thailand Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Malaysia Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 82. Malaysia Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Latin America Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 84. Latin America Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 85. Latin America Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
    Figure 86. Latin America Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
    Figure 87. Mexico Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 88. Mexico Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 89. Brazil Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 90. Brazil Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Argentina Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 92. Argentina Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 94. Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 95. Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
    Figure 96. Middle East and Africa Oxaprozin Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
    Figure 97. Turkey Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 98. Turkey Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 99. Saudi Arabia Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 100. Saudi Arabia Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. UAE Oxaprozin Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 102. UAE Oxaprozin Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. Oxaprozin Active Pharmaceutical Ingredients Value Chain
    Figure 104. Channels of Distribution
    Figure 105. Distributors Profiles
    Figure 106. Bottom-up and Top-down Approaches for This Report
    Figure 107. Data Triangulation
    Figure 108. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3900

This license allows only one user to access the PDF.
Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart